Chinese herbal medicine for primary liver cancer therapy: perspectives and challenges K Li, K Xiao, S Zhu, Y Wang, W Wang Frontiers in Pharmacology 13, 889799, 2022 | 20 | 2022 |
Prognostic Role of TIGIT Expression in Patients with Solid Tumors: A Meta‐Analysis K Xiao, K Xiao, K Li, P Xue, S Zhu Journal of Immunology Research 2021 (1), 5440572, 2021 | 20 | 2021 |
Potential Molecular Mechanisms of Chaihu‐Shugan‐San in Treatment of Breast Cancer Based on Network Pharmacology K Xiao, K Li, S Long, C Kong, S Zhu Evidence‐Based Complementary and Alternative Medicine 2020 (1), 3670309, 2020 | 18 | 2020 |
Integrated analysis of lncRNA-mediated ceRNA network reveals a prognostic signature for hepatocellular carcinoma JR Sun, CF Kong, KM Xiao, JL Yang, XK Qu, JH Sun Frontiers in Genetics 11, 602542, 2020 | 9 | 2020 |
A systematic review and meta-analysis of randomized controlled trials on treating ulcerative colitis by the integration method of heat-clearing, damp-excreting, spleen … ZJ Jia, ZH Yang, CX Jia, KM Xiao, YQ Niu, J Chen, SJ Duan, SK Yao, Y Li World Journal of Traditional Chinese Medicine 6 (1), 74-89, 2020 | 9 | 2020 |
Unveiling potential mechanisms of Spatholobi Caulis against lung metastasis of malignant tumor by network pharmacology and molecular docking F Xie, M Wang, Y Su, K Xiao, X Chu, S Long, L Li, X Zhang, P Xue, S Zhu Evidence‐Based Complementary and Alternative Medicine 2022 (1), 1620539, 2022 | 6 | 2022 |
Prognostic and immunological value of LTB4R in pan-cancer S Long, S Ji, K Xiao, P Xue, S Zhu Mathematical Biosciences and Engineering 18 (6), 9336-9356, 2021 | 3 | 2021 |
Research progress on the treatment of advanced prostate cancer with Olaparib. SU Yi-Xin, YU Cheng-Feng, XUE Peng, LI Lin-Lu, X Kun-Min, ... Neoplasma 68 (6), 2021 | 2 | 2021 |
Multiple Classes of Antibiotic Use in Infancy and Allergic Disease in Childhood KM Xiao, SX Liang, Y Liu JAMA pediatrics 174 (10), 1002-1002, 2020 | 2 | 2020 |